Steve Schey
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 28
- Multiple Myeloma Research and Treatments 25
- Acute Myeloid Leukemia Research 3
- Oncology 19
- Peptidase Inhibition and Analysis 9
- Cancer Treatment and Pharmacology 3
- Co-authors
- Henrik Møller (5 shared papers)Karen Phekoo (5 shared papers)Matthew Streetly (8 shared papers)Ian Hann (1 shared paper)Richard Stevens (1 shared paper)A Oakhill (1 shared paper)Stein Kvaløy (1 shared paper)Raoul Herbrecht (1 shared paper)
- Journals
- Blood (9 papers)British Journal of Haematology (6 papers)Bone Marrow Transplantation (3 papers)European Journal Of Haematology (3 papers)British Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Steve Schey
45 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 80
- Hematology 596
- Genetics 228
- Oncology 418
- Pathology and Forensic Medicine 263
- Infectious Diseases 270
Countries citing papers authored by Steve Schey
This map shows the geographic impact of Steve Schey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Schey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Schey more than expected).
Fields of papers citing papers by Steve Schey
This network shows the impact of papers produced by Steve Schey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Schey. The network helps show where Steve Schey may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Schey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 325 | |
| 2 | 2004 | 222 | |
| 3 | 2010 | 103 | |
| 4 | 2004 | 99 | |
| 5 | 2001 | 99 | |
| 6 | The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. | 2006 | 82 |
| 7 | 1999 | 72 | |
| 8 | 2007 | 71 | |
| 9 | 2010 | 51 | |
| 10 | 2007 | 31 | |
| 11 | 2012 | 29 | |
| 12 | 2005 | 29 | |
| 13 | 2017 | 21 | |
| 14 | 2000 | 17 | |
| 15 | 2018 | 16 | |
| 16 | 2015 | 15 | |
| 17 | 2022 | 15 | |
| 18 | Life-threatening motor neurotoxicity in association with bortezomib. | 2006 | 13 |
| 19 | 2004 | 11 | |
| 20 | 1993 | 11 |
About Steve Schey
Steve Schey is a scholar working on Hematology, Oncology, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (25 papers), Protein Degradation and Inhibitors (10 papers), Peptidase Inhibition and Analysis (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (596 citations), Genetics (228 citations), Oncology (418 citations), Pathology and Forensic Medicine (263 citations) and Infectious Diseases (270 citations). Steve Schey has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Henrik Møller, Karen Phekoo, Matthew Streetly, Ian Hann, Richard Stevens, A Oakhill, Stein Kvaløy, Raoul Herbrecht, B Gibson and H. G. Prentice. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, European Journal Of Haematology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.